Toxicity-dependent feasibility bounds for the escalation with overdose control approach in phase I cancer trials. (2017)

First Author: Wheeler GM

Attributed to: Adaptive Clinical Trials funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/sim.7280

PubMed Identifier: 28295513

Publication URI: http://europepmc.org/abstract/MED/28295513

Type: Journal Article/Review

Volume: 36

Parent Publication: Statistics in medicine

Issue: 16

ISSN: 0277-6715